Clinical Trials Directory

Trials / Terminated

TerminatedNCT02372695

Effect of Paricalcitol Over Vessel Wall

Effect of Paricalcitol Over Vessel Wall: Pleiotropic Analogues Vitamin D Effects

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Effice Servicios Para la Investigacion S.L. · Industry
Sex
All
Age
50 Years – 75 Years
Healthy volunteers
Not accepted

Summary

To provide evidence based prospectives of the potential benefit effects of paricalcitol, an analog of vitamin D, over the prevention / retardation of the progression of neoangiogenesis (vessels), atherosclerosis and vascular calcification.

Detailed description

Providing prospective results based on evidence of potential beneficial effects of paricalcitol, an analogue of vitamin D in the prevention / delay of progression of neoangiogenesis (vessels), atherosclerosis and vascular calcification.

Conditions

Interventions

TypeNameDescription
DRUGParicalcitol

Timeline

Start date
2012-07-01
Primary completion
2013-05-01
Completion
2013-05-01
First posted
2015-02-26
Last updated
2015-02-26

Source: ClinicalTrials.gov record NCT02372695. Inclusion in this directory is not an endorsement.

Effect of Paricalcitol Over Vessel Wall (NCT02372695) · Clinical Trials Directory